Sign Up Today and Learn More About Arbor Biotechnologies Stock
Invest in or calculate the value of your shares in Arbor Biotechnologies or other pre-IPO companies through EquityZen's platform.
About Arbor Biotechnologies Stock
Founded
2016
Headquarters
Cambridge, MA, US
Total Funding
12.2M
Industries
Science and Engineering, Health Care, Biotechnology
None
Arbor Biotechnologies Press Mentions
Stay in the know about the latest news on Arbor Biotechnologies
Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., To Board
citybiz • Jun 26, 2025
Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors
globenewswire • Jun 25, 2025
Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors
biospace • Jun 25, 2025
Exclusive: Mikael Dolsten joins gene editing startup's board and eyes 'opportunities' with new FDA leaders
endpoints • Jun 24, 2025
CRISPR Market is expected to generate a revenue of USD 12.78 Billion by 2032, Globally, at 15.85% CAGR: Verified Market Research®
prnewswire • Jun 02, 2025
Join now and verify your accreditation status to gain access to:
- Arbor Biotechnologies Current Valuation
- Arbor Biotechnologies Stock Price
- Arbor Biotechnologies Management
- Available deals in Arbor Biotechnologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Arbor Biotechnologies Cap Table and Funding History by Share Class and Liquidity Preferences
- Arbor Biotechnologies Revenue and Financials
- Arbor Biotechnologies Highlights
- Arbor Biotechnologies Business Model
- Arbor Biotechnologies Risk Factors
- Arbor Biotechnologies Research Report from SACRA Research
Trading Arbor Biotechnologies Stock
How to invest in Arbor Biotechnologies stock?
Accredited investors can buy pre-IPO stock in companies like Arbor Biotechnologies through EquityZen funds. These investments are made available by existing Arbor Biotechnologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Arbor Biotechnologies stock?
Shareholders can sell their Arbor Biotechnologies stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
